SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S)

Therapeutic indications

SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is indicated for:

Active immunisation to prevent COVID-19 caused by SARS-CoV-2

Population group: both men and women, only adults (18 years old or older)

SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intramuscular - 0.5 ml once

Contraindications

SARS-CoV-2 Spike glycoprotein (Ad26.COV2-S) is contraindicated in the following cases:

Capillary leak syndrome (CLS)

Capillary leak syndrome

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner